U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07115043) titled 'A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors' on July 16.
Brief Summary: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Study Start Date: July 29
Study Type: INTERVENTIONAL
Condition:
Melanoma
Non-small Cell Lung Cancer
Squamous Cell Carcinoma (Skin)
Renal Cell Carcinoma
Merkel Cell Carcinoma
Triple Negative Breast Cancer
Head and Neck Squamous Cell Carcinoma
Gastric Cancer/Gastroesophageal Junction Cancer
High Grade Serous Ovarian Carcinoma
Intervention:
DRUG: AZD6750
AZD6750- CD8 guided IL-2
DRU...